Devin Incerti

804 total citations
31 papers, 530 citations indexed

About

Devin Incerti is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Devin Incerti has authored 31 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in Devin Incerti's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Pregnancy and preeclampsia studies (3 papers). Devin Incerti is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Pregnancy and preeclampsia studies (3 papers). Devin Incerti collaborates with scholars based in United States, Switzerland and United Kingdom. Devin Incerti's co-authors include Warren Stevens, Desi Peneva, Thanh G.N. Ton, Jeroen P. Jansen, Henry Lee, Tiffany Shih, Baha M. Sibai, George A. Macones, Anupam B. Jena and Gianluca Baio and has published in prestigious journals such as Cancer Research, American Journal of Obstetrics and Gynecology and Statistics in Medicine.

In The Last Decade

Devin Incerti

31 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devin Incerti United States 13 194 179 77 60 58 31 530
P Barton United Kingdom 9 206 1.1× 97 0.5× 59 0.8× 16 0.3× 205 3.5× 15 602
G Albouze France 12 50 0.3× 89 0.5× 57 0.7× 49 0.8× 100 1.7× 17 797
Rebecca Burne Canada 10 83 0.4× 70 0.4× 38 0.5× 9 0.1× 48 0.8× 22 302
Nicky Lieberman Israel 13 82 0.4× 37 0.2× 44 0.6× 12 0.2× 68 1.2× 23 500
Rochelle Winikoff Canada 14 197 1.0× 207 1.2× 7 0.1× 100 1.7× 18 0.3× 28 985
Eli Westerlund Sweden 13 79 0.4× 91 0.5× 16 0.2× 28 0.5× 38 0.7× 31 531
Sandra E. Brooks United States 17 498 2.6× 54 0.3× 66 0.9× 13 0.2× 162 2.8× 39 1.1k
Marion Cortet France 16 225 1.2× 273 1.5× 9 0.1× 14 0.2× 44 0.8× 49 960
Steven E. Marx United States 16 41 0.2× 59 0.3× 54 0.7× 9 0.1× 222 3.8× 42 701
Gbenga Olorunfemi South Africa 11 50 0.3× 83 0.5× 10 0.1× 17 0.3× 71 1.2× 62 331

Countries citing papers authored by Devin Incerti

Since Specialization
Citations

This map shows the geographic impact of Devin Incerti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin Incerti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin Incerti more than expected).

Fields of papers citing papers by Devin Incerti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devin Incerti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin Incerti. The network helps show where Devin Incerti may publish in the future.

Co-authorship network of co-authors of Devin Incerti

This figure shows the co-authorship network connecting the top 25 collaborators of Devin Incerti. A scholar is included among the top collaborators of Devin Incerti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin Incerti. Devin Incerti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skarbinski, Jacek, Heidi Fischer, Vennis Hong, et al.. (2023). Real‐World Evidence to Supplement Randomized Clinical Trials: Tocilizumab for Severe COVID‐19 Pneumonia vs. a Cohort Receiving Standard of Care. Clinical Pharmacology & Therapeutics. 114(5). 1073–1081. 3 indexed citations
2.
Jansen, Jeroen P., Devin Incerti, & Thomas A Trikalinos. (2023). Multi‐state network meta‐analysis of progression and survival data. Statistics in Medicine. 42(19). 3371–3391. 4 indexed citations
3.
Ton, Thanh G.N., et al.. (2022). Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and R. Pharmaceutical Statistics. 22(1). 194–204. 10 indexed citations
4.
Skarbinski, Jacek, Liyan Liu, Vennis Hong, et al.. (2022). Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19. BMJ Open. 12(10). e060358–e060358. 1 indexed citations
5.
Pouwels, Xavier, Chris Sampson, Renée J.G. Arnold, et al.. (2022). Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey. Value in Health. 25(4). 473–479. 11 indexed citations
6.
Incerti, Devin, Michael T. Bretscher, Ray Lin, & Chris Harbron. (2022). A meta‐analytic framework to adjust for bias in external control studies. Pharmaceutical Statistics. 22(1). 162–180. 2 indexed citations
7.
Huepenbecker, Sarah P., Jason D. Wright, Mary K. Downer, et al.. (2022). Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstetrics and Gynecology. 140(5). 758–767. 3 indexed citations
8.
Incerti, Devin, Shemra Rizzo, Xiao Li, et al.. (2021). Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA. BMJ Open. 11(4). e047121–e047121. 26 indexed citations
9.
Incerti, Devin, et al.. (2021). Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genetics in Medicine. 24(1). 109–118. 34 indexed citations
10.
Incerti, Devin, et al.. (2020). The economic burden of kidney graft failure in the United States. American Journal of Transplantation. 20(5). 1323–1333. 21 indexed citations
11.
Incerti, Devin, Howard Thom, Gianluca Baio, & Jeroen P. Jansen. (2019). R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment. Value in Health. 22(5). 575–579. 27 indexed citations
12.
Incerti, Devin, Jeffrey R. Curtis, Jason Shafrin, Darius Lakdawalla, & Jeroen P. Jansen. (2019). A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis. PharmacoEconomics. 37(6). 829–843. 17 indexed citations
13.
Jansen, Jeroen P., Devin Incerti, & Mark T. Linthicum. (2019). Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project. PharmacoEconomics. 37(11). 1313–1320. 22 indexed citations
14.
Incerti, Devin, John Browne, Caroline Huber, et al.. (2019). An empirical tool for estimating the share of unmet need due to healthcare inefficiencies, suboptimal access, and lack of effective technologies. BMC Health Services Research. 19(1). 113–113. 2 indexed citations
15.
Incerti, Devin, et al.. (2018). An Open-Source Toolkit for Developing Flexible Evidence-Based Decision and Simulation Models for Value Assessment in Oncology with R. Value in Health. 21. S223–S223. 1 indexed citations
16.
Incerti, Devin. (2018). The optimal allocation of campaign funds in U.S. House elections. Electoral Studies. 56. 102–113. 3 indexed citations
17.
Incerti, Devin, Nicholas Summers, Thanh G.N. Ton, et al.. (2018). The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States. MDM Policy & Practice. 3(1). 3442430323–3442430323. 22 indexed citations
18.
Frasco, Melissa A., et al.. (2017). Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferonβ-1a. Journal of Medical Economics. 20(10). 1074–1082. 13 indexed citations
19.
Shahabi, Ahva, Desi Peneva, Devin Incerti, Kimmie McLaurin, & Warren Stevens. (2017). Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants. PharmacoEconomics - Open. 2(1). 53–61. 32 indexed citations
20.
Stevens, Warren, Tiffany Shih, Devin Incerti, et al.. (2017). Short-term costs of preeclampsia to the United States health care system. American Journal of Obstetrics and Gynecology. 217(3). 237–248.e16. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Barton Breakdown of academic impact, for papers by G Albouze Breakdown of academic impact, for papers by Rebecca Burne Breakdown of academic impact, for papers by Nicky Lieberman Breakdown of academic impact, for papers by Rochelle Winikoff Breakdown of academic impact, for papers by Eli Westerlund Breakdown of academic impact, for papers by Sandra E. Brooks Breakdown of academic impact, for papers by Marion Cortet Breakdown of academic impact, for papers by Steven E. Marx Breakdown of academic impact, for papers by Gbenga Olorunfemi
Rankless by CCL
2026